How to Diagnose Azotemia
Azotemia is diagnosed by measuring serum creatinine and blood urea nitrogen (BUN) levels, which reveal elevated nitrogenous waste products in the blood. 1, 2
Initial Laboratory Assessment
The diagnosis begins with:
- Serum creatinine measurement - the primary marker for kidney function
- Blood urea nitrogen (BUN) - elevated in azotemia
- BUN:creatinine ratio - helps differentiate causes (ratio >20:1 suggests prerenal causes) 3, 4
Azotemia is defined as the laboratory finding of elevated BUN and creatinine, representing the kidney's inability to excrete nitrogenous wastes and maintain fluid/electrolyte homeostasis. 1
Categorizing the Type of Azotemia
Once azotemia is identified, determine whether it is prerenal, renal (intrinsic), or postrenal:
Prerenal Azotemia (Functional)
- History of volume depletion, hypotension, decreased cardiac output, or renal artery occlusion 4, 1
- Urinary indices:
- Response to fluid challenge: Serum creatinine should decrease by ≥0.3 mg/dL from baseline with volume expansion (1 g/kg albumin up to 100 g/day) 4
Renal Azotemia (Intrinsic)
- Evidence of structural kidney damage
- Urinalysis findings: Hematuria, proteinuria (>500 mg/dL), abnormal urinary sediment, cellular casts 3, 4
- Urinary indices:
- Imaging: Small echogenic kidneys on ultrasound indicate chronic structural disease 4
- No response to fluid challenge - creatinine remains elevated despite volume repletion 4
Postrenal Azotemia (Obstructive)
- Renal ultrasound is the key diagnostic test - shows hydronephrosis if obstruction present 1, 6
- Perform ultrasound in high-risk patients (known urologic disease, single kidney, pelvic mass) - 29% will have obstruction 6
- In low-risk patients, ultrasound only needed if azotemia persists despite standard treatment - only 1% have obstruction 6
- Postrenal causes account for <3% of all azotemia cases 1
Additional Diagnostic Studies
When structural renal disease is suspected:
- Daily serum creatinine monitoring to assess acute kidney injury (AKI) stage 4
- Chest radiography, urine and blood cultures to exclude infection 4
- Diagnostic paracentesis in cirrhotic patients to rule out spontaneous bacterial peritonitis 4
- Kidney biopsy may be needed to differentiate glomerulonephritis from other causes 1
Emerging biomarkers (not yet widely available):
- Neutrophil gelatinase-associated lipocalin (NGAL) - urinary NGAL >220-244 mg/g creatinine suggests acute tubular necrosis rather than prerenal azotemia 4
- Cystatin C combined with creatinine provides more accurate GFR estimation 4
Critical Pitfalls to Avoid
- Don't rely solely on FENa in patients on diuretics - it becomes unreliable; use FEUrea instead 4
- Don't assume prerenal azotemia based only on low FENa - in cirrhosis, FENa <1% has 100% sensitivity but only 14% specificity 4
- Don't delay ultrasound in high-risk patients - obstruction is reversible if caught early 1, 6
- Don't attribute azotemia to comorbid conditions without confirmation - presence of diabetes doesn't prove diabetic nephropathy 2
- Avoid nephrotoxic medications during evaluation - NSAIDs, ACE inhibitors, ARBs can worsen azotemia 4, 7